IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Inciardi, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.430
AS - Asia 1.577
EU - Europa 899
SA - Sud America 417
AF - Africa 38
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.368
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.359
SG - Singapore 643
BR - Brasile 357
CN - Cina 335
HK - Hong Kong 250
DE - Germania 191
VN - Vietnam 133
IT - Italia 132
FI - Finlandia 106
GB - Regno Unito 89
RU - Federazione Russa 84
IE - Irlanda 78
TR - Turchia 74
UA - Ucraina 49
IN - India 39
CA - Canada 38
FR - Francia 29
BD - Bangladesh 26
PL - Polonia 23
MX - Messico 22
SE - Svezia 22
CZ - Repubblica Ceca 20
AR - Argentina 19
ZA - Sudafrica 18
ES - Italia 13
JP - Giappone 12
BE - Belgio 11
ID - Indonesia 11
AT - Austria 10
SA - Arabia Saudita 10
CL - Cile 8
IQ - Iraq 8
NL - Olanda 8
VE - Venezuela 8
BG - Bulgaria 7
PY - Paraguay 7
AU - Australia 6
EC - Ecuador 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
PK - Pakistan 5
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
LV - Lettonia 4
BO - Bolivia 3
CH - Svizzera 3
KZ - Kazakistan 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
PA - Panama 2
PT - Portogallo 2
UZ - Uzbekistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
LK - Sri Lanka 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
TW - Taiwan 1
Totale 5.368
Salva come PNG Salva come JPEG
Città #
Singapore 285
Ashburn 250
Hong Kong 249
Fairfield 196
Beijing 136
New York 128
Chandler 127
Princeton 126
Woodbridge 95
Los Angeles 90
Helsinki 86
Houston 84
Wilmington 80
Seattle 77
The Dalles 75
Cambridge 72
Dublin 72
Munich 69
Istanbul 64
Dallas 59
Jacksonville 46
Ho Chi Minh City 45
São Paulo 42
Ann Arbor 39
Moscow 35
Hanoi 31
San Francisco 31
London 29
Redondo Beach 29
Buffalo 28
Brescia 26
Milan 26
Frankfurt am Main 25
San Diego 25
Shanghai 23
Chicago 21
Des Moines 21
Brno 19
Warsaw 19
Montreal 18
Chennai 14
Düsseldorf 12
Nuremberg 12
Romola 12
Santa Clara 12
Tokyo 12
Toronto 12
Boston 11
Brussels 11
Denver 10
Johannesburg 10
Querétaro 10
Washington 10
Brooklyn 9
Turku 9
Belo Horizonte 8
Da Nang 8
Lappeenranta 8
Poplar 8
Pune 8
Atlanta 7
Guarulhos 7
Orem 7
Phoenix 7
Porto Alegre 7
Rome 7
Stockholm 7
Guangzhou 6
Haiphong 6
Menlo Park 6
Mexico City 6
Rio de Janeiro 6
Verona 6
Amman 5
Brasília 5
Cleveland 5
Fortaleza 5
Kyiv 5
Lauterbourg 5
Padova 5
Paris 5
Portsmouth 5
São José dos Campos 5
Tianjin 5
Bắc Ninh 4
Cape Town 4
Curitiba 4
Gunzenhausen 4
Haikou 4
Hải Dương 4
Jeddah 4
Jinan 4
Kilburn 4
Manchester 4
Mumbai 4
Newark 4
Riga 4
Strasbourg 4
Tampa 4
Vienna 4
Totale 3.408
Salva come PNG Salva come JPEG
Nome #
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 175
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 164
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 138
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 117
Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease 115
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 107
Implications for the Care of Patients with COVID-19 and Inflammatory Myocardial Disease-Reply 105
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 103
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 99
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 98
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 94
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 92
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 91
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure 88
The prognostic value of serial troponin measurements in patients admitted for COVID-19 88
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 87
Early Small Creatinine Shift Predicts Contrast-Induced Acute Kidney Injury and Persistent Renal Damage after Percutaneous Coronary Procedures: Early creatinine shift predicts CI-AKI 87
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 87
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 86
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 85
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 84
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 83
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 82
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 81
Endothelial dysfunction in COVID-19 patients assessed with Endo-PAT2000 79
Cardiac biomarkers and mortality in COVID-19 infection: A review 78
Vericiguat for Heart Failure with Reduced Ejection Fraction 77
Cardiac Mechanics Assessment and the Risk of Heart Failure in the General Population 76
Association of Echocardiographic Measures of Left Atrial Function and Size With Incident Dementia 76
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 75
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 74
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 73
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 72
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 70
Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy 70
Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans 69
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 68
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 66
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 65
Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial 64
Combined pre- and post-capillary pulmonary hypertension in left heart disease 63
Mitral regurgitation, edge-to-edge valve repair and the left atrium: one step beyond the left ventricle? 62
Association of Left Atrial Structure and Function With Heart Failure in Older Adults 62
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 61
Usefulness of strain imaging echocardiography in arrhythmogenic right ventricular cardiomyopathy: clinical perspective 61
Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults 61
Right cardiac chambers' involvement as the first manifestation of recurrent complex karyotype acute myeloid leukemia 60
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 59
Left Atrial Structure and Function of the Amyloidogenic V122I Transthyretin Variant in Elderly African Americans 59
Chemotherapy cardiotoxicity: Cardioprotective drugs and early identification of cardiac dysfunction 57
Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography 57
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 55
Left atrial structure and function and the risk of death or heart failure in atrial fibrillation 54
Mitral regurgitation and dyspnoea: the expanding role of mitral effective regurgitant orifice among un-selected patients 54
How to incorporate left atrial strain in the diagnostic algorithm of left ventricular diastolic dysfunction 54
Association of Physical Activity With Left Atrial Function in Older Adults: The ARIC Study 53
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 53
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 51
Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy 50
Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction 49
Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction 49
Left Atrial Mechanical Dysfunction and the Risk for Ischemic Stroke in People Without Prevalent Atrial Fibrillation or Stroke : A Prospective Cohort Study 48
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 48
Left atrium: A forgotten biomarker and a potential target in cardiovascular medicine 47
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 47
Long COVID-19: A Tangled Web of Lungs, Heart, Mind, and Gender 46
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 45
Criteria for Iron Deficiency in Patients With Heart Failure 44
Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art 43
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC Study 43
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 43
Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure? 40
Epicardial adipose tissue in heart failure: risk factor or mediator? 39
Type of hospitalisations and in-hospital outcomes in the Italian coronary care unit network at the time of COVID-19 pandemic: the BLITZ-COVID19 Registry 35
Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction 34
Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy 33
Reply to "Clinical implications of left atrial changes after optimization of medical therapy in heart failure patients" 30
Identification and quantification of congestion in heart failure: a work in progress 28
Totale 5.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021488 0 0 0 0 0 14 230 56 52 50 70 16
2021/2022498 51 32 17 17 38 21 22 26 51 48 42 133
2022/2023475 81 33 11 13 24 126 1 39 77 1 38 31
2023/2024663 29 6 68 52 45 137 26 17 158 8 12 105
2024/20251.336 12 22 20 187 89 124 149 51 125 112 273 172
2025/20261.782 283 358 239 459 298 145 0 0 0 0 0 0
Totale 5.465